Hang Seng SCHK Innovative Drug Select IndexHSSCPBValuation Analysis
Valuation Snapshot
Based on the blended 10-year P/E and P/B percentiles, this index currently sits in the “Fair Value Range” zone.
As of 2026-10-16, Hang Seng SCHK Innovative Drug Select Index (HSSCPB) trades at a P/E of 32.70x and a P/B of 3.00x.
Longitudinal percentile comparison: P/E sits at the 31.59th percentile over the trailing 10Y window (vs. 34.24th percentile over 3Y); P/B sits at the 61.3th percentile over the trailing 10Y window (vs. 58.05th percentile over 3Y).
Data refreshes weekly and is for reference only, not investment advice.
Want the full picture on whether Hang Seng SCHK Innovative Drug Select Index (HSSCPB) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E & P/B percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|
| P/E | 32.70 | ||||
| P/B | 3.00 |